Insmed Inc (INSM)
25.28
+1.14
(+4.72%)
USD |
NASDAQ |
Apr 23, 16:00
25.28
0.00 (0.00%)
After-Hours: 16:27
Insmed Free Cash Flow (Quarterly): -132.97M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -132.97M |
| September 30, 2023 | -139.19M |
| June 30, 2023 | -127.68M |
| March 31, 2023 | -149.70M |
| December 31, 2022 | -107.84M |
| September 30, 2022 | -90.41M |
| June 30, 2022 | -105.20M |
| March 31, 2022 | -106.86M |
| December 31, 2021 | -85.27M |
| September 30, 2021 | -76.93M |
| June 30, 2021 | -78.93M |
| March 31, 2021 | -129.46M |
| December 31, 2020 | -68.31M |
| September 30, 2020 | -59.42M |
| June 30, 2020 | -37.83M |
| March 31, 2020 | -60.61M |
| December 31, 2019 | -57.44M |
| September 30, 2019 | -66.96M |
| June 30, 2019 | -90.64M |
| March 31, 2019 | -77.88M |
| December 31, 2018 | -74.92M |
| September 30, 2018 | -67.34M |
| June 30, 2018 | -57.76M |
| March 31, 2018 | -72.78M |
| December 31, 2017 | -49.92M |
| Date | Value |
|---|---|
| September 30, 2017 | -38.68M |
| June 30, 2017 | -36.68M |
| March 31, 2017 | -37.33M |
| December 31, 2016 | -58.73M |
| September 30, 2016 | -32.28M |
| June 30, 2016 | -29.78M |
| March 31, 2016 | -30.12M |
| December 31, 2015 | -27.95M |
| September 30, 2015 | -24.88M |
| June 30, 2015 | -25.17M |
| March 31, 2015 | -26.15M |
| December 31, 2014 | -14.47M |
| September 30, 2014 | -23.82M |
| June 30, 2014 | -18.49M |
| March 31, 2014 | -12.98M |
| December 31, 2013 | -14.17M |
| September 30, 2013 | -16.51M |
| June 30, 2013 | -5.442M |
| March 31, 2013 | -11.37M |
| December 31, 2012 | -9.094M |
| September 30, 2012 | -9.215M |
| June 30, 2012 | -7.315M |
| March 31, 2012 | -5.678M |
| December 31, 2011 | -6.489M |
| September 30, 2011 | -8.495M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-149.70M
Minimum
Mar 2023
-37.83M
Maximum
Jun 2020
-93.24M
Average
-90.41M
Median
Sep 2022
Free Cash Flow (Quarterly) Benchmarks
| NeuroMetrix Inc | -1.496M |
| Intra-Cellular Therapies Inc | -2.062M |
| Rhythm Pharmaceuticals Inc | -29.38M |
| Amylyx Pharmaceuticals Inc | 13.20M |
| AN2 Therapeutics Inc | -17.07M |